oncology

Latest Posts

OS Therapies (NYSE: OSTX) is a most cancers immunotherapy firm engaged within the improvement...

Market

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness | AlphaStreet

Depth Therapeutics, Inc. (NASDAQ: INTS) is a medical biotechnology firm engaged within the discovery...

Market

Depth Therapeutics is establishing a brand new discipline of localized most cancers discount: CEO | AlphaStreet

Knowledge from the IGNYTE major analysis reveals clinically significant exercise throughout all subgroups, together...

Market

Replimune Presents Main Evaluation Knowledge from IGNYTE Scientific Trial of RP1 Mixed with Nivolumab in Anti-PD1 Failed Melanoma at European Society for Medical Oncology...

Therapy knowledge had been analyzed from 3,276 circumstances of sufferers with newly identified EGFR...

Market

Black Diamond Therapeutics Presents Actual-World Therapy Practices and Affected person Outcomes in Newly Identified NSCLC Sufferers with Non-Classical Mutations on the European Society for...

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech firm targeted on shifting new...

Market

Ocean Biomedical (NASDAQ: OCEA) Analysis Abstract | AlphaStreet

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a new-generation biotechnology agency that works to speed...

Market

Ocean Biomedical (NASDAQ: OCEA) Analysis Abstract | AlphaStreet – Coin Trolly